ADTXAditxt, Inc.
0.0050USD+138.10%Mkt Cap: 4.99M $P/E: —3d ago
Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to …